All In MedTech

Device Trial Radar · NCT06110117

Assess Efficacy and Safety of a Nasal Spray in Adults With Dry or Irritated Nose

Open Clinical Investigation to Evaluate Efficacy and Safety of the Medical Device "Sterimar Stop & Protect Irritation & Dryness" in Adults With Dry or Irritated Nose

Last checked: Nov 20, 2026Latest source record: Nov 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

70

Actual

Start

Oct 27, 2023

Primary completion

Mar 15, 2024

Study completion Nov 4, 2024

Sponsor

Lead sponsor
Church & Dwight Company, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 31, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to test symptom relief in subjects suffering from irritated or dry nasal passages. The main question it aims to answer is whether use of the nasal spray provides relief from dry nose symptoms. Participants will use the product for one week and report on the severity of their symptoms before and during use.

Conditions

  • Dry Nose

Interventions

  • Sterimar Stop & Protect Irritation & DrynessDevice

    One or two nasal sprays will be administered to each nostril for a minimum of 2 times per day up to a maximum of 6 times per day for seven days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in patient-reported total irritation score from baselineTime frame: One week of product use.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Eurofins Dermscan Poland

    Gdansk, Poland

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.